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Introduction
The plasma membrane of higher eukaryotic cells serves as a 
platform for transmitting and processing extracellular and in-
tracellular information (Grecco et al., 2011). In addition, the 
plasma membrane and the associated cell cortex can also act 
as an excitable medium capable of lateral signal propagation 
(Iglesias and Devreotes, 2012; Wu et al., 2013; Bement et al., 
2015; Barnhart et al., 2017; Miao et al., 2017; van Haastert et 
al., 2017). The underlying network architecture of a typical ex-
citable medium is based on a component that controls its own 
activity by coupled self-amplifying and self-inhibiting mech-
anisms (Murray, 2002; Iglesias and Devreotes, 2012). A time 
delay in the self-inhibiting mechanism makes such systems 
more robust with regard to kinetic parameters of the underlying 
signaling network (Stricker et al., 2008). If an excitable system 
is stimulated above a certain threshold, it generates a maximal 
response followed by an insensitive, refractory period. With 
spatial coupling, for example via diffusion, such systems can 
generate propagating wave fronts of excited signal activity (Ig-
lesias and Devreotes, 2012).
Excitable systems are a key element in the development 
of multicellular organisms and current models of chemotaxis. 
In this context, signaling networks that are centered on the Rho 
GTPases RhoA, Rac1, or Cdc42 are thought to serve a role 
in exploratory processes such as cortical excitability to direct 
cleavage furrow positioning in mitotic and meiotic oocytes (Be-
ment et al., 2015), cortical instabilities in the actomyosin cortex 
of the Caenorhabditis elegans embryo (Nishikawa et al., 2017), 
or protrusion dynamics in small migrating cells, including Dic-
tyostelium discoideum and neutrophils (Xiong et al., 2010; Igle-
sias and Devreotes, 2012; Tang et al., 2014; Yang et al., 2016). 
However, cell migration in larger cell types is thought to be 
more complex, involving coordinated cell protrusion and con-
traction (Burnette et al., 2011).
Although several studies show that excitable signal trans-
duction networks can control cell protrusion (Xiong et al., 
2010; Iglesias and Devreotes, 2012; Tang et al., 2014; Yang et 
al., 2016; Barnhart et al., 2017; Miao et al., 2017; van Haastert 
et al., 2017), the role of excitability in controlling subcellular 
contractility is less clear. In nonmuscle cells, cell contraction is 
driven by actomyosin dynamics downstream of a signal path-
way, including the small GTPase RhoA, Rho kinase 1 (ROCK1) 
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and ROCK2, and myosin light chain kinase/phosphatase (Ri-
ento and Ridley, 2003). Rho is thought to be key to the spa-
tiotemporal regulation of this pathway. However, Rho activity 
is also known to stimulate actin polymerization via other ef-
fectors, including formins of the diaphanous family (Kühn and 
Geyer, 2014). Because of the influence of Rho activity on multi-
ple distinct cellular processes, the analysis of bulk Rho activity 
alone is not sufficient to untangle its cellular functions.
Here, we focus on the role of Rho in regulating contrac-
tion in adherent cells by simultaneous imaging of endogenous 
Rho activity and Myosin II dynamics. Using this strategy, we 
uncovered spontaneous, subcellular pulses and propagating 
waves of Rho activity that are coupled to subcellular patterns of 
Myosin II localization and actomyosin contraction.
Our analysis of the connectivity between these com-
ponents and regulatory factors reveals an activator-inhibitor 
network, in which Rho self-amplification via the guanine nucle-
otide exchange factor (GEF) GEF-H1 (ARH GEF2) is coupled 
to Rho inhibition via delayed activation and accumulation of 
actomyosin and the associated RhoGAP Myo9b. Our experi-
mental manipulations show that this signaling network is crit-
ical for the spontaneous emergence of pulses and propagating 
waves of Rho activity. Furthermore, we show that network dy-
namics are modulated by the expression level of associated reg-
ulators and the elasticity of the extracellular matrix to control 
cell contractility dynamics.
Results
Local Rho activity pulses in cultured 
adherent cells
In a previous study, we found that the Rho effectors FHOD1 
and nonmuscle myosin heavy chain IIa (Myosin IIa, MYH9) 
accumulate near the leading edge of spreading U2OS cells to 
cooperate in the generation of a subpopulation of stress fibers 
called actin arcs (Schulze et al., 2014). During cell protrusion, 
such stress fibers are thought to form a structural basis to cou-
ple substrate adhesion and extension of the cells’ leading edge 
via actin polymerization (Burnette et al., 2011). Here, we found 
that in addition to this expected localization, spontaneous pulses 
of Myosin IIa association with the cortical actin cytoskeleton 
occur near the cell center. To investigate the signaling network 
that controls these patterns, we combined measurements of 
effector plasma membrane association with activity measure-
ments of Rho itself. We used a fluorescent protein fusion of the 
GTPase-binding domain (GBD) of the Rho effector Rhotekin as 
a Rho activity sensor (Benink and Bement, 2005). This domain 
was shown to bind specifically to the active form of the related 
GTPases RhoA, RhoB, and RhoC (collectively termed Rho in 
this article) but neither to inactive Rho nor to active Rac1 or 
Cdc42 (Reid et al., 1996; Ren et al., 1999). We used total inter-
nal reflection fluorescence (TIRF) microscopy to measure the 
recruitment of the Rhotekin GBD to local areas of increased 
endogenous Rho activity at the plasma membrane. To reduce 
potential competition between the sensor and endogenous ef-
fectors, we expressed Rhotekin-GBD under the control of the 
very weak delCMV promotor (Watanabe and Mitchison, 2002). 
To quantify spatiotemporal activity patterns, we developed 
custom-built ImageJ macros to measure several parameters, in-
cluding the standard deviation of the local signal intensity (see 
Materials and methods).
Using this strategy, we observed highly dynamic, local 
pulses of Rho activity (Fig. 1, a–f; and Video 1, top). Interest-
ingly, these dynamic patterns were detected in resting, adherent 
cells, which were neither stimulated nor perturbed by pharma-
cological compounds. These dynamic changes in signal inten-
sity were not observed in cells expressing only the fluorescent 
protein, which was used as a soluble control sensor (Fig. 1, b 
and c; and Fig. S1, a and b). To test whether signal pulses de-
tected with the Rhotekin-GBD sensor might be caused by mem-
brane movement in and out of the TIRF field, we also included 
an additional, membrane-anchored control sensor that consists 
of the fluorescent protein, coupled to the C-terminal targeting 
sequence of K-Ras (EGFP-CAAX). Neither the soluble nor the 
membrane-anchored control sensor displayed local pulses in 
their signal (Fig. S1, a–d). Furthermore, small changes in solu-
ble and membrane-anchored control sensor signal did not cor-
relate with signal changes of the Rhotekin-GBD sensor, clearly 
showing that Rhotekin-GBD signal changes do not derive from 
movements of the plasma membrane (Fig. S1, a–d). Pixel-based 
spatiotemporal autocorrelation analysis revealed that sponta-
neous Rho activity patterns were focused to small subcellular 
regions with a decay length of 1.9 ± 0.3 µm and a half-time of 
21.7 ± 4.4 s (Fig. 1, d–f).
During cell spreading, we also observed dynamic Rho 
activity changes, as well as occasional, more prominent Rho 
activity peaks (Fig. S1, e and f, yellow arrow; and Fig. S1 g). 
These Rho activity peaks were coupled to increased Myosin IIa 
plasma membrane localization. However, Myosin IIa was dis-
tributed in two distinct populations that differed both in their 
cellular localization and coincidence with increased Rho ac-
tivity (Fig. S1, e–g). Myosin IIa was either concentrated near 
the cell edge over time periods of several minutes (Fig. S1 f, 
magenta arrow) or transiently in more central cell attachment 
regions (Fig. S1 f, yellow arrow). Only transient myosin cortex 
associations correlated with increased Rho activity patterns in 
space and time (Fig. S1, e–g). To quantify the Myosin IIa and 
Rho sensor signals with respect to the distance between the cell 
centroid and the cell edge, we transformed cell images of ir-
regular shapes into a normalized, circular shape (Möhl et al., 
2012). As shown in Fig. S1 h, the mean intensity of the soluble 
cytosolic control sensor (EGFP) is nearly equal across the cell 
attachment area. Mean Rho activity signals are also distributed 
quite homogenously, but their change over time as measured 
by the standard deviation was strongly increased in central cell 
regions (Fig. S1 i). Mean Myosin IIa signals were maximal near 
the cell edge; however, temporal signal changes were again pre-
dominantly observed in central cell regions.
These analyses thereby confirm the presence of two dis-
tinct Myosin IIa populations in spreading cells: a relatively 
static population of highly concentrated Myosin IIa near the 
cell edge and a more dynamic population in central regions that 
overlap with increased Rho activity dynamics (Fig. S1, e–i). 
Importantly, local Myosin IIa pulses were also detected in rest-
ing cells coexpressing fluorescently labeled actin, showing that 
Myosin IIa cortex association dynamics is independent of the 
overexpression of the Rho activity sensor (Fig. S1, j and k).
Mechanism of Rho activity self-amplification
We next investigated the source of the observed, spatiotem-
poral Rho activity dynamics, which included both highly ir-
regular occasional peaks (Fig. 1 b) and more regular, locally 
recurring activity maxima (Fig. S2 b). Because of this apparent 
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periodicity, we excluded a purely stochastic cause and sought 
to identify the mechanism that can explain this dynamic be-
havior. Several distinct network topologies that include a neg-
ative feedback are known to generate periodic activity changes 
(Tyson et al., 2003). A subset of these systems, so-called ac-
tivator–inhibitor networks, also include a positive feedback 
(Tyson et al., 2003). This network topology can also form the 
basis for excitable systems (Iglesias and Devreotes, 2012), 
such as those that enable the propagation of action potentials 
in neurons (Fitzhugh, 1961; Nagumo et al., 1962), chemical 
waves (Winfree, 1984), or of Rho activity in the cortex of oo-
cytes (Bement et al., 2015).
In principle, Rho could either be an integral part of a 
dynamic signaling network, or it could simply be positioned 
downstream of a signaling network that generates activity 
pulses independently of Rho. To investigate the underlying 
network structure that generates the observed Rho activity dy-
namics in adherent cells, we introduced an acute, global Rho 
activity perturbation and measured how this acute perturbation 
affects Rho activity dynamics.
Microtubule depolymerization is a rapid method that is 
known to increase Rho activity in cells by releasing the micro-
tubule-bound RhoA activating GEF-H1 (Krendel et al., 2002; 
Chang et al., 2008). As expected, shortly after application of the 
Figure 1. Spontaneous pulses of Rho activity. (a) Representative TIRF image of Rho activity in resting U2OS cells (see also Video 1, top). (b) Local Rho 
activity dynamics within white boxes in a, normalized to global mean intensity values. No pulses are observed in cells expressing the control sensor (see 
also Fig. S1, a–d, for direct comparison of raw signal data). (c) Standard deviation of local Rho activity signal dynamics (percentage of mean intensity; 
n ≥ 37 cells from three experiments). (d–f) Representative spatiotemporal autocorrelation function derived from the cell shown in panel a. (e and f) Values 
represent half-time (e) and half-distance (f) ± SEM (n = 39 cells from three experiments). (g–k) Rho activity was stimulated by nocodazole-induced microtu-
bule depolymerization. This induced recurrent local Rho activity pulses with increased amplitude. (g) TIRF images of the Rho activity sensor before and after 
nocodazole treatment (see also Video 1, bottom). (h) Kymographs corresponding to regions in g (yellow rectangles). (i) Rho activity signal within the white 
boxes in g. (j and k) Baseline Rho activity (j) and standard deviation of local Rho signal (k; percentage of mean intensity) before and after nocodazole 
addition (n = 43 cells from three experiments). Frame rate is 3/min. Bars, 10 µm. ***, P < 0.001 (c, unpaired t test; j and k, paired t test). For detailed 
analyses of unperturbed, spreading cells, see Fig. S1 (e–i).
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microtubule-depolymerizing drug nocodazole, we observed a 
significant (P < 0.001) increase in Rho activity sensor baseline 
levels (Fig. 1, g–j; and Fig. S2 a). In addition, we also observed 
a clear increase in the standard deviation of local Rho activity 
signals (P < 0.001; Fig. 1, i, h, and k; and Video 1, bottom), 
and we observed propagating Rho activity waves (Fig. S2 c), 
suggesting that Rho and/or GEF-H1 activity are integral parts 
of an excitable signal transduction network. Neither the soluble 
nor the membrane-anchored control sensors showed increased 
dynamics in the presence of nocodazole (Fig. S2, d–f), further 
strengthening our previous statement that Rhotekin-GBD signal 
changes do not derive from movements of the plasma membrane.
Next, we tested whether the Rho activator GEF-H1 might 
mediate the increase in Rho activity dynamics after nocodazole 
treatment. Indeed, overexpression of WT or microtubule-bind-
ing–deficient C53R mutant was sufficient to increase Rho ac-
tivity pulse amplitude in the absence of nocodazole (Fig. 2, a 
and b; and Video 2). In contrast, a GEF-deficient double mu-
tant (C53R, Y393A) had no effect. Furthermore, we frequently 
observed propagating waves of Rho activity in the presence of 
GEF-H1 WT (34.8 ± 7.4% SEM) and GEF-H1 C53R (47.4 ± 
8.4% SEM), but not in cells expressing the control construct (0 
± 0.0% SEM; n ≥ 55 cells from four experiments). GEF-H1–
mediated waves propagated with a relatively constant velocity 
of 0.39 ± 0.14 µm/s (GEF-H1 WT) and 0.31 ± 0.12 µm/s (GEF-
H1 C53R; Video 3, top; n = 29 and n = 17 cells from three ex-
periments; mean values ± standard deviation). In addition to the 
stimulation of wave propagation, we also frequently observed 
annihilation of two colliding waves (Fig. S2, g and h). Such spa-
tiotemporal patterns (wave propagation and mutual annihilation 
of wave fronts) are typically observed in excitable systems that 
combine both positive and negative feedback regulation (Igle-
sias and Devreotes, 2012).
Because GEF-H1 is a well-known activator of Rho, we 
hypothesized that it might play a role in forming a positive 
feedback to amplify Rho activity within local pulses and propa-
gating waves. To enable such a positive feedback, GEF-H1 not 
only needs to activate Rho but also needs to be activated by 
Rho (e.g., by being recruited to areas of increased Rho activity). 
A recent study indeed showed that the Lbc family of GEFs, 
which includes GEF-H1, can interact with active RhoA via their 
Pleckstrin homology (PH) domains (Medina et al., 2013). In-
terestingly, this interaction surface does not overlap with the 
interaction between inactive RhoA and the Dbl homology do-
main of an Lbc GEF family member (Chen et al., 2010). Thus, 
a GEF that is recruited to active Rho via the PH domain would 
still be able to activate inactive Rho with its Dbl homology do-
main. Together, these interactions would be able to close a pos-
itive feedback loop to amplify Rho activity (Fig. 2 c). Indeed, 
cross-correlation analysis showed that GEF-H1 is rapidly re-
cruited to sites of Rho activity, thus enabling mutual stimulation 
between these components (Fig. 2, d–g; and Video 4). In addi-
tion, maximal GEF-H1 accumulation was nearly simultaneous 
with Rho activation, and on average only shifted slightly ahead 
by 2.5 ± 0.7s (P < 0.001; one-sample t test for Δt being dif-
ferent from 0 s; value ± SEM). In contrast, no significant time 
shift was observed using EGFP as a control (Fig. 2, h–k; and 
Video 4). We next tested, if the interaction between the GEF-
H1 PH domain and active Rho is essential for stimulating Rho 
activity pulses. To test this, we introduced two point mutations 
in the PH domain (F539A/I541E) that disrupt a hydrophobic 
patch that was previously found to be critical for the interaction 
between Lbc-type GEFs and active RhoA (Medina et al., 2013). 
Indeed, this GEF-H1 mutant was unable to stimulate Rho activ-
ity patterns (Fig. 2 l).
Furthermore, depletion of GEF-H1 via RNAi showed 
that GEF-H1 is not only essential for the nocodazole-induced 
increase in Rho activity dynamics but also required for Rho 
activity pulses in non–nocodazole-treated, resting cells (Fig. 2, 
m and n; Video 3, bottom; and Fig. S2, i and j). Both in the 
absence and presence of nocodazole, Rho activity dynamics 
were rescued by overexpressing the siRNA-resistant WT GEF-
H1, but not using the resistant GEF-H1 construct with the mu-
tated PH domain (F539A/I541E) or the GEF-deficient mutant 
(Y393A). Thus, GEF activity, as well as the interaction between 
GEF-H1 and active RhoA, is crucial for the generation of Rho 
activity dynamics, both in resting cells and after their noco-
dazole-induced stimulation.
In contrast, overexpression of the Rho GEF Ect2, which 
does not belong to the Lbc family, only had a small effect on 
the standard deviation of local Rho activity, and we did not 
observe any propagating Rho activity waves (0 ± 0.0% SEM; 
Fig. 2 o). The N-terminally truncated, constitutively active mu-
tant Ect2 414–882 stimulated Rho activity dynamics only in a 
small subset of cells (21.7 ± 11.1% SEM; Fig. 2 o, magenta). In 
contrast to GEF-H1–induced Rho activity waves, which were 
predominantly localized to central cell regions, waves induced 
in this subset of Ect2 414–882–expressing cells propagated 
within the cell periphery (Fig. 2 p). Interestingly, Ect2 414–882 
was not enriched at sites of increased Rho activity but was in-
stead excluded from these regions (Fig. 2, p–r). Furthermore, 
depletion of Ect2 via RNAi did not reduce but instead slightly 
increased Rho activity dynamics (Fig.  2  s and Fig. S2 k). In 
contrast, overexpression of another Lbc family GEF, called 
LARG, stimulated Rho activity pulses that are very similar to 
those induced by GEF-H1 (Fig. S2, l and m). Together, this 
shows that in contrast to the Lbc family members GEF-H1 and 
LARG, Ect2 does not act as a positive feedback mediator to 
drive Rho activity dynamics.
The active form of RhoA is expected to diffuse much 
slower in the plasma membrane than the inactive, cytosolic 
form (Frick et al., 2007). Therefore, RhoA itself might be con-
centrated within local Rho activity pulses. Indeed, we did ob-
serve highly significant local pulses and propagating waves of 
RhoA plasma membrane association, which closely correlated 
with the localization of the Rho activity sensor (Fig. S3, a–d). 
Furthermore, these pulses were stimulated by nocodazole treat-
ment, showing that RhoA can amplify its own local concentra-
tion via the GEF-H1–stimulated positive feedback loop (Fig. 
S3 e). However, in direct comparison, the amplitude of RhoA 
localization dynamics was lower than the amplitude of Rho ac-
tivity sensor dynamics. Thus, local Rho activity pulses result 
from the combination of Rho self-activation and local accumu-
lation, the latter presumably because of the slow diffusion of 
the active form of Rho.
Spatiotemporal mapping of Rho 
GTPase signaling
Previous studies suggested that cross talk between Rho GTPases 
can control their subcellular activity patterns (Benink and Be-
ment, 2005; Machacek et al., 2009; Guilluy et al., 2011). To map 
the timing of Rac1/Cdc42 activity in relation to Rho activation, 
we used temporal cross-correlation analysis. In these experi-
ments, we enhanced the sensitivity of our correlation analysis 
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Figure 2. GEF-H1 mediates Rho activity self-amplification. (a) TIRF images of the Rho activity sensor mCherry-Rhotekin-GBD in U2OS cells coexpressing 
EGFP (control) or EGFP-GEF-H1 C53R (see also Video 2). Kymographs correspond to arrows. (b) Standard deviation of local Rho signal (n ≥ 55 cells from 
four experiments). (c) Proposed mechanism of Rho activity amplification via GEF-H1. (d–k) Temporal cross-correlation analysis of the Rho activity sensor 
mCherry-Rhotekin-GBD and EGFP-GEF-H1 WT (d–g) or EGFP localization (h–k) in nocodazole-treated cells. (d and h) Individual images of TIRF measure-
ments (see also Video 4). (e and i) Intensity measurements from boxes in d and h. (f and j) Temporal cross-correlation functions and frequency distribution 
(g and k) of cross-correlation maxima derived from f and j (n ≥ 30 cells from three experiments; error bars represent 95% confidence interval). (l) Standard 
deviation of local Rho activity signal in cells coexpressing GEF-H1 C53R or GEF-H1 C53R F539A I541E (n ≥ 124 cells from three experiments). (m) TIRF 
images of the Rho activity sensor mCherry-Rhotekin-GBD in U2OS cells treated with nontargeting (nt) or GEF-H1 siRNA. Kymographs correspond to arrows 
(see also Video 3, bottom). (n) Standard deviation of local Rho activity signal in cells treated with nt or GEF-H1 siRNA and coexpressing control (EGFP), 
siRNA-resistant GEF-H1 WT, siRNA-resistant GEF-H1 F539A I541E, or siRNA-resistant GEF-H1 Y393A (n ≥ 82 cells from four experiments). (o) Standard 
deviation of local Rho activity signal in cells coexpressing control (EGFP) or Ect2 constructs (n ≥ 36 cells from three experiments; measurements from a 
small subpopulation of cells that show wave propagation are marked in magenta). (p) Representative TIRF images from the subpopulation of cells marked 
magenta in panel o. Kymographs correspond to yellow circular line. (q) Intensity measurements within the regions indicated by white boxes in panel p.  
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by stimulating robust Rho activity pulses via nocodazole- 
induced release of GEF-H1 from microtubules. To measure 
Rac1 and Cdc42 activity, we used fluorescent protein fusions 
of the GBDs of the corresponding specific effectors p67phox 
(NCF2; Lapouge et al., 2000) and WASP (WAS; Symons et al., 
1996). The p67phox GBD was not yet used to study Rac1 activity 
in living cells via TIRF microscopy. We therefore first validated 
this probe by combining sensor signal measurements with op-
togenetic switching of Rac1 activity (Fig. S3, f–h). As shown 
in Fig. S3, i–l (and Video 4), we did not observe altered Rac1 
activity within or near Rho activity peaks. Also, in contrast to 
the expected segregation of Cdc42 and Rho activity (Benink 
and Bement, 2005; Machacek et al., 2009), we observed that 
Cdc42 activity largely overlapped with Rho activity peaks with 
variable delays between their maxima of 0–20 s (Fig. S3, m–p; 
and Video 4). These results show that neither Rac1 nor Cdc42 
activity precedes Rho activity amplification and therefore can-
not trigger Rho activity pulses.
Next, we used cross-correlation analyses to study 
well-characterized cellular functions of Rho activity: stimula-
tion of actin polymerization and myosin activation. We observed 
strong cross-correlation of Rho activity and actin plasma mem-
brane localization (Fig. 3, a–d; and Video 5, top) with a delay of 
11.0 ± 1.1 s (P < 0.001; one-sample t test; value ± SEM). The 
localization of FHOD1, which is activated by ROCK-mediated 
phosphorylation downstream of RhoA (Takeya et al., 2008), 
correlated with Rho activity with a shorter delay of 6.3 ± 0.8s 
(P < 0.001; one-sample t test; value ± SEM; Fig. S3, q–t). This 
suggests that actin nucleation, polymerization or recruitment 
is stimulated within the cell cortex close to the plasma mem-
brane downstream of Rho activity via effectors such as FHOD1. 
Furthermore, we observed similar spatiotemporal pulses and 
propagating waves of FHOD1 in 48.1 ± 18.1% (SEM) of plu-
ripotent, bacterial artificial chromosome (BAC)–transgenic 
mouse embryonic stem cells (n = 57 cells from five exper-
iments) and spontaneous Rho activity pulses in several types 
of resting and unstimulated adherent cells (unpublished data), 
showing that this phenomenon is not limited to transformed 
U2OS osteosarcoma cells (Fig. S3, u–w). Furthermore, FHOD1 
was expressed at low levels under its endogenous promoter in 
BAC-transgenic mouse embryonic stem cells. Thus, pulses and 
propagating waves of this Rho effector are independent of ad-
ditional protein overexpression, in particular concerning signal-
ing network components and associated factors such as the Rho 
activity sensor or Myosin II.
Interestingly, the association between Myosin IIa and 
the cell cortex correlated strongly with Rho activity patterns 
in space and time with a pronounced delay (Fig.  3, e–l; and 
Video 5, two bottom panels). A similar delay was observed in 
nocodazole-treated cells (39.5 ± 2.4 s; P < 0.001; one-sample 
t test; value ± SEM; Fig.  3, e–h) and resting cells that were 
not treated with nocodazole and did not overexpress GEF-H1 
(34.9 ± 2.7s; P < 0.001; one-sample t test; value ± SEM; Fig. 3, 
i–l). This pronounced lag indicates the presence of a cellular 
mechanism that acts as a timer to delay maximal Myosin IIa 
accumulation downstream of Rho activity. We hypothesized 
that this delay might be caused by the relatively slow turnover 
of Myosin II (Chang and Kumar, 2015) and contractile forces 
(Vicente-Manzanares et al., 2009), which can generate a corti-
cal flow that slowly transports and further locally concentrates 
myosin in cells. To test this hypothesis, we sought to determine 
whether the temporally correlated Rho activity and Myosin IIa 
cortex association pulses were linked to actomyosin contractile 
flow. We first measured the temporal evolution of flow fields of 
Myosin IIa translocation via spatiotemporal image correlation 
spectroscopy (STI CS; see Materials and methods). We then cal-
culated the divergence of these flow fields to identify “sources” 
that correspond to expansive flow or “sinks” that correspond 
to contractile flow of the actomyosin cell cortex (Fig. 3, m–o). 
Interestingly, maximal flow (i.e., inward, negative divergence) 
preceded maximal Myosin IIa cortex accumulation (Fig. 3 p). 
Temporal cross-correlation analysis revealed a significant lag 
of 35.1 ± 3.4 s (SEM) between these events (Fig. 3, q–r). Con-
tractile flow peaks were often associated with roughly circular 
nodes and were followed by symmetrical Myosin IIa flow to-
ward the node center (Fig. 3, m–o, white boxes between t = 15 s 
and t = 45  s). The temporal sequence of events suggests that 
actomyosin contractile flow indeed contributes to local myosin 
accumulation (Fig. S4 a).
Mechanism of Rho activity self-inhibition
To support robust activity pulses, the positive feedback that am-
plifies Rho activity needs to be coupled to a time-delayed nega-
tive feedback (Stricker et al., 2008). Because of their significant 
delays (11.0 ± 1.1 and 39.5 ± 2.4 s; mean values ± SEM) with 
respect to Rho activation, actin and Myosin IIa are potential 
candidates to act as platforms to recruit inhibitors that could 
shut down Rho activity. Indeed, we observed strong spatio-tem-
poral cross-correlation between Rho activity and localization 
of inactive mutants of the actin-associated Rho-specific GT-
Pase-activating proteins (GAPs) Myo9b (Müller et al., 1997) 
and p190RhoGAP (ARH GAP35; p190ARhoGAP; Arthur and 
Burridge, 2001; Fig. 4, a–d; and Fig. S4, b–e). Those inactive 
mutants have previously been used as proxies to study the lo-
calization of their corresponding WT GAPs without disturbing 
cellular phenotype (van den Boom et al., 2007). Using these 
mutants we measured significant delays in the plasma mem-
brane association of the GAPs after Rho activity peaks in the 
range between 2.4 and 3 s, suggesting that they act downstream 
of Rho activity. It should be noted that our measurement of the 
delay represents an underestimation caused by the delay of Rho 
sensor plasma membrane association after Rho activation. We 
also observed significant cross-correlation using the correspond-
ing WT proteins (Fig. 4, e–h; and Fig. S4, f–i). Interestingly, 
overexpression of WT, but not GAP-deficient, Myo9b lead to an 
increase in pulse frequency that was associated with a decrease 
in peak width (Fig. 4, b, f, i, and j; and Video 6). In cells that 
express GAP-deficient Myo9b, Rho activity pulses occurred ir-
regularly and were separated by a period of 2–7 min (Fig. 4 b). 
The corresponding power spectrum therefore only shows a 
broad maximum at low frequencies (Fig. 4 j). In contrast, cells 
that express WT Myo9b showed more regular oscillations with 
(r) Temporal cross-correlation function from subpopulation of cells marked magenta in panel n (n = 6 cells from two experiments; error bars represent 95% 
confidence interval). (s) Standard deviation of local Rho activity signal in cells treated with control or Ect2 siRNA (n ≥ 75 cells from three experiments). 
For representative Western blots of GEF-H1 and Ect2 siRNA knockdown, see Fig. S2 (i and k). Frame rate is 3/min (a, b, and l–s) or 20/min (d–k). Bars, 
10 µm. **, P < 0.01; ***, P < 0.001 (b, n, and o, analysis of variance, Dunnett’s post-test; g and k, one-sample t test; and l and s, unpaired t test).
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a period of 30–50 s (Fig. 4 f). The corresponding power spec-
trum therefore contains additional peaks at higher frequencies 
(Fig. 4 j). The measured delay of WT Myo9b after Rho activity 
pulses was smaller than that of the GAP mutant, but it was still 
significant. These observations suggest that Myo9b might act as 
a mediator of negative feedback; the delayed cross-correlation 
suggests that it is activated downstream of Rho, and the effect 
on pulse frequency and peak width suggests that it can also act 
upstream of Rho to inhibit its activity. In contrast to Myo9b, 
overexpression of GEF-H1 WT or C53R had the opposite effect 
on pulse width (Fig. 4 i). Together, this suggests that the shape 
of Rho activity peaks is controlled by a balance between activat-
ing regulators, such as GEF-H1, that stimulate prolonged Rho 
activity increase and inhibitory regulators, such as Myo9b, that 
accelerate subsequent shut down of Rho activity.
These analyses show that Myo9b is able to rapidly shut 
down Rho activity pulses. In the absence of Myo9b overexpres-
sion, additional, slower mechanisms might participate in Rho 
activity inhibition. Myosin IIa is particularly well suited to me-
diate such a delayed shut down because of the long delay of 
Figure 3. Local Rho activity peaks correlate with actomyosin localization and cell contraction. (a–l) Temporal cross-correlation analysis of the Rho activity 
sensor mCherry-Rhotekin-GBD and plasma membrane localization of actin (a–d; EGFP-actin; see also Video 5, top), Myosin IIa (e–l; EGFP-NMH CIIa; see 
also Video 5, middle and bottom). (m–r) Temporal cross-correlation analysis of Myosin IIa signal and contractile flow. Nocodazole-treated (a–h and m–r) 
or (i–l) untreated, resting U2OS cells. For additional cross-correlation analyses between Rho activity and Rac1, Cdc42, and FHOD1 localization, see 
Fig. S3. (a, e, i, and m) TIRF images. (n) Color-coded vector fields depicting Myosin IIa flux in m measured via STI CS. (o) Contractile and expansive flow 
of Myosin IIa structures derived from the divergence of the STI CS vector map field in panel n. (b, f, j, and p) Intensity or contractile flow measurements 
within the regions indicated by white boxes in panels a, e, i, m, and o. Temporal cross-correlation functions (c, g, k, and q) and frequency distribution of 
cross-correlation maxima (d, h, l, and r) derived from panels c, g, k, and q (n ≥ 15 cells from at least three experiments; error bars represent 95% confi-
dence interval). Frame rate is 20/min. Bars, 10 µm. ***, P < 0.001 (d, h, l, and r, one-sample t test).
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its accumulation after Rho activation. Indeed, it is known that 
Myosin IIa can inhibit the activity of Dbl-type GEFs, including 
GEF-H1 (Lee et al., 2010). In addition, myosin-driven cortical 
flow (Fig. 3, m–r) could also efficiently concentrate actomyo-
sin-associated RhoGAPs, including Myo9b. Interestingly, GEF-
H1 and Myosin IIa overlap in space and time, thereby enabling 
this inhibitory interaction (Fig.  5, a and b). Furthermore, the 
onset of GEF-H1 peaks coincided with minimal or decreasing 
Myosin IIa accumulation (Fig. 5 b), which is reflected in a strong 
anticorrelation between Myosin IIa and GEF-H1 localization 
(Fig. 5, c and d). This further supports the idea that Myosin IIa 
can inhibit GEF-H1 and thus would act both downstream and 
upstream of Rho activity. If this is the case, then both inhibition 
of the ROCK that activates Myosin II downstream of RhoA and 
direct inhibition of Myosin II activity should interfere with Rho 
activity pulsing (Figs. 5 e and S5 b). Indeed, if cells were treated 
with either the Myosin II inhibitor blebbistatin or the ROCK in-
hibitor Y27632, activity pulses were strongly inhibited (Fig. 5, 
f–i; Fig. S5; and Video 7). Furthermore, the increased tempo-
ral lag between Rho activity pulse peaks after partial inhibition 
of the Rho–ROCK–Myosin II pathway, as seen in the example 
shown in Fig. S5 (c–f), suggests that the activity of this pathway 
acts as a timer to control Rho inactivation. In particular, the last 
node in this pathway, Myosin II, has a very slow turnover at 
the cell cortex (Chang and Kumar, 2015). This is in contrast to 
Myo9b, which turns over at an ∼10-fold higher rate (van den 
Boom et al., 2007). This could also explain the distinct Rho 
pulse kinetics with or without Myo9b overexpression.
Figure 4. Local Rho activity pulses are mod-
ulated by associated GAP and GEF activities. 
(a–h) Temporal cross-correlation analysis of the 
Rho activity sensor mCherry-Rhotekin-GBD and 
RhoGAP Myo9b localization using a GAP- 
deficient mutant (a–d; R1695M) or WT EGFP 
fusion proteins (e–h) in nocodazole-treated 
U2OS cells (see also Video 6). The cross-cor-
relation analyses between Rho activity and 
p190RhoGAP are shown in Fig. S4. TIRF im-
ages (a and e), and intensity measurements 
(b and f) within the boxes in panels a and 
e. Temporal cross-correlation functions (c and 
g) and frequency distribution (d and h) of 
cross-correlation maxima derived from panels 
c and g (n ≥ 21 cells from three experiments; 
error bars represent 95% confidence interval). 
(i) Peak width of Rho activity signal (n ≥ 21 
cells from three experiments; red lines repre-
sent mean). (j) Fourier analysis of Myo9b WT 
and R1695M mutant signal intensity (n ≥ 21 
cells from three experiments). Frame rate is 
20/min. Bars, 10 µm. *, P < 0.05; ***, P < 
0.001 (d and h, one-sample t test; i, analysis 
of variance, Dunnett’s post-test).
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In our experiments, high-amplitude Rho activity pulses 
always induced high-amplitude myosin peaks, which were as-
sociated with clearly detectable contractile flow. However, pre-
sumably because of the slow turnover kinetics, the Myosin IIa 
signal often accumulated over the course of several weaker and 
shorter pulses and was not always associated with individual, 
very weak Rho activity peaks. It is thus possible that the GAP 
activity of actin-associated regulators such as Myo9b might be 
sufficient to mediate negative feedback in these short Rho activ-
ity peaks with small amplitude. Collectively, our analyses reveal 
multiple actomyosin-associated pathways that can mediate neg-
ative feedback regulation of Rho activity at distinct timescales.
Rho activity pulses are coupled to matrix 
elasticity
Our experiments show that Rho cooperates with its own activator, 
GEF-H1, to form a positive feedback that is combined with a 
delayed negative feedback via recruiting the Rho/GEF-H1 inhib-
itors Myo9b and Myosin IIa. In combination, these feedbacks act 
on the scale of molecules to form a self-organizing system that is 
capable of spontaneously generating spatiotemporal activity pat-
terns. Interestingly, this self-organizing mechanism is linked to 
Myosin IIa activity, leading to local pulses of contractile flow. We 
hypothesize that these pulses of contractile flow are coupled to 
the extracellular space via focal adhesions, providing a potential 
link between the underlying signaling network and extracellular 
matrix elasticity (Fig. 6 a). More rigid substrates enable the gen-
eration of stronger intracellular forces, and these increased forces 
can stimulate the interaction between Myosin IIa and actin fila-
ments and the assembly dynamics of bipolar myosin filaments 
(Luo et al., 2012). We therefore hypothesized that intracellular 
contraction pulses might be stimulated on more rigid substrates.
Indeed, the amplitude and rate of spontaneous Myosin IIa 
localization pulses were significantly increased when cells were 
plated on stiffer substrates (300 or 500 kPa) as compared with 
softer substrates (10 kPa). Similar effects were observed in resting 
(Fig. 6, b–d; and Video 8) and nocodazole-treated cells (Fig. 6, 
e–g). This shows that the intracellular excitable signal system that 
forms the basis of spontaneous contractility pulses is coupled to 
and influenced by the cells’ elastic extracellular environment.
Figure 5. Myosin IIa acts both downstream 
and upstream of Rho activity patterns. (a–d) 
Temporal cross-correlation analysis of GEF-H1 
(EGFP-GEF-H1 WT) and Myosin IIa (mCherry- 
NMH CIIa) in nocodazole-treated U2OS 
cells. (a) Individual images of TIRF measure-
ments. (b) Intensity measurements within white 
boxes in panel a.  (c and d) Temporal cross- 
correlation functions (c) and frequency distri-
bution (d) of anticorrelation maxima derived 
from panel c (n = 37 cells from three exper-
iments; error bars represent 95% confidence 
interval). (e) Schematic of the proposed Rho 
activity based signaling network and inhibition 
by blebbistatin. The inhibition of ROCK with 
Y27632 is shown in Fig. S5. (f) TIRF images of 
the Rho activity sensor mCherry-Rhotekin-GBD 
and Myosin IIa (EGFP-NMH CIIa) before and 
after 50  µM blebbistatin treatment (1  h; see 
also Video 7). Kymographs correspond to the 
white lines in the images above. (g) Intensity 
measurements within white regions indicated 
in f. (h and i) Standard deviation of local Rho 
activity and myosin signal (n ≥ 10 cells from 
three experiments; see Fig. S5 a for vehicle 
controls). Frame rate is 20/min (a–d) or 3/min 
(f–j). Bars, 10 µm. *, P < 0.05; ***, P < 0.001 
(d, one-sample t test; h and I, paired t test).
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Discussion
Cells adapt their shape to their environment primarily by alter-
ing the dynamic organization of their actin cytoskeleton. How-
ever, the mechanisms that regulate these dynamic cell-shape 
changes in space and time are still poorly understood. Here, we 
show that myosin-based cell contraction is controlled by a sig-
naling network that combines positive and negative feedback on 
the regulatory small GTPase Rho. Depending on the expression 
level of the positive feedback mediator GEF-H1, this network 
manifests distinct dynamic behaviors. In the absence of GEF-
H1, the negative feedback is dominant. By itself, a system based 
on negative feedback displays homeostasis and counteracts the 
effect of a stimulus (Tyson et al., 2003). Here, this homeostasis 
can limit the formation of stress fibers. This can be seen in anal-
ogy to proprioception in the control of muscle contractility, in 
which an afferent nerve limits muscle contraction stimulated by 
an efferent nerve (Johnson et al., 2008). In individual cells, an 
analogous control system could play a role in balancing protru-
sive and contractile cell-shape changes.
At endogenous GEF-H1 levels and in the absence of 
nocodazole, the positive and negative feedbacks are in balance, 
leading to basal subcellular contractility pulses of varying 
amplitude and intermittent, stronger Rho activity pulses. 
These dynamic activity changes offer a mechanism for cells 
to continuously probe their environment via associated, dy-
namic cell contractions and mechanosensitive focal adhesions. 
Indeed, we found that pulses of this cell contractility network 
are modulated by the mechanical properties of the surround-
ing matrix. Interestingly, we find that contractility pulses are 
localized to subcellular areas of the plasma membrane, pre-
sumably because of the local accumulation of slowly dif-
fusing, active Rho. Such localized contraction pulses enable 
local sensing of extracellular cues while preventing global 
contraction of the entire cell, which could otherwise lead to 
detachment from its matrix.
Several developmental processes are controlled by the 
elastic properties of the extracellular environment. For ex-
ample, differentiation of mesenchymal stem cells to neurons, 
muscle cells, or bone-forming osteoblasts can be triggered by 
defined ranges of matrix stiffness and involve Myosin II ac-
tivity (Engler et al., 2006). Our study reveals a novel, matrix 
elasticity–modulated signaling network that forms spatiotem-
poral patterns of protein activity linked to cellular contraction. 
These spatiotemporal patterns might then be decoded into elas-
ticity-dependent cell differentiation decisions. Local pulses of 
Figure 6. Modulation of Rho activity pulse 
frequency by matrix elasticity. (a) Schematic 
of the proposed cross talk between cellular 
contractility signaling and matrix elasticity. 
Untreated, resting (b–d) or nocodazole-treated 
(e–g) U2OS cells were grown on matrices of 
different elasticities and visualized via TIR FM 
(b–d) or spinning disk microscopy (e–g; see 
also Video  8). (b and e) Individual images 
of Myosin IIa localization; kymographs corre-
sponding to white arrows. Arrows indicate ac-
tivity pulse peaks at the cell border (magenta) 
or near the cell center (yellow). (c, d, f, and g) 
Local standard deviation and frequency of my-
osin activity pulses (c and d; n ≥ 53 cells from 
three experiments) in unstimulated cells or after 
nocodazole-induced Rho activation (f and g; 
n ≥ 23 cells from five experiments). Frame rate 
is 20/min. Bars, 10 µm. **, P < 0.01; ***, P 
< 0.001 (c, d, f, and g, unpaired t test).
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contractility were also observed during Drosophila melano-
gaster gastrulation (Martin et al., 2009; Kerridge et al., 2016), 
suggesting that the excitable Rho/myosin system we describe 
here might be conserved during evolution. Interestingly, the 
activity of the GEF-H1–related Drosophila protein RhoGEF2 
is increased during gastrulation (Martin et al., 2009). It would 
be interesting to investigate, if this regulator mediates positive 
feedback of Rho activity in that system.
Increasing Rho self-amplification either by releasing GEF-
H1 from microtubules or by overexpression of WT or active 
GEF-H1 stimulates the formation of propagating contractility 
waves. The ability to form these waves is presumably a con-
sequence of increased Rho self-amplification, which leads to 
more robust and thereby self-propagating local Rho activation. 
Interestingly, wave propagation of cytoskeletal components or 
their regulators was observed in several distinct contexts (Xiong 
et al., 2010; Case and Waterman, 2011; Iglesias and Devreotes, 
2012; Tang et al., 2014; Bement et al., 2015), suggesting that 
the underlying network topology of an activator–inhibitor sys-
tem with excitable properties might be a more general motif to 
control the spatiotemporal organization of cytoskeletal dynam-
ics. For example, myosin-independent waves of actin polym-
erization were recently observed during meiosis in the cortex 
of Xenopus laevis and starfish oocytes and embryos (Bement 
et al., 2015). In that context, the GEF Ect2 was found to be 
an essential, positive regulator of system dynamics. In contrast, 
we found that Ect2 is dispensable for spontaneous Rho activity 
pulses in resting adherent cells and that Ect2 activation induced 
a distinct wave propagation phenotype in a small subpopulation 
of cells. Thus, these results show that Ect2 and GEF-H1 trigger 
distinct wave propagation mechanisms in distinct cellular con-
texts. Interestingly, seemingly cyclic RhoB activation patterns 
were observed after nocodazole treatment of primary human 
endothelial cells (Reinhard et al., 2016). Such patterns were not 
observed for the related GTPases RhoA and RhoC. It is thus 
interesting to speculate that human endothelial cells might also 
use an excitable signaling network to control Rho activity, and 
it might be interesting to investigate which Rho isoform is rele-
vant for the activity patterns we observe in our study.
In conclusion, we present a Rho/myosin–based activa-
tor–inhibitor signaling network that controls localized patterns 
of cell contractility. This system exhibits irregular or periodic 
pulses, as well as wave propagation, which enable local sam-
pling at subcellular scales. We propose that this network forms 
the basis of self-limited, exploratory stress fiber organization 
and that it is modulated by mechanical and biochemical cues 
to actively shape individual cells and their arrangement in 
multicellular structures.
Materials and methods
Cell culture and reagents
Human U2OS osteosarcoma cells (HTB-96; ATCC) were cultured in 
DMEM-GlutaMAX supplemented with 10% FBS, 50 U/ml penicillin, 
and 50 µg/ml streptomycin at 37°C and 5% CO2. In some experiments, 
cells were treated with 30 µM of the microtubule-depolymerizing com-
pound nocodazole (45–90 min) to stimulate RhoA activity. Pharmaco-
logical treatments started 72–78 h after siRNA transfection or 14–20 h 
after transfection of plasmid DNAs. For live-cell imaging, cells were 
plated onto collagen type I–coated glass-bottom dishes (1 h, c = 0.01 
mg/ml) either before transfection of plasmid DNA or to investigate 
cell spreading 0.5–1 h before imaging. To study the effect of matrix 
elasticity, cells were plated on soft elastomeric substrates made of 
two different cross-linked silicone rubber systems. For spinning disk 
microscopy in the presence of nocodazole, Sylgard 184 (Dow Corn-
ing GmbH) was used with an elasticity of 500 kPa (20:1 ratio, base to 
cross-linker WT/WT) and 10 kPa (55:1). For TIRF microscopy in the 
absence of nocodazole, LS-3252 (NuSil Technology) was used with an 
elasticity of 10 kPa (1.4:1 ratio, part A to part B WT/WT) and 300 kPa 
(1:1.6, part A to part B WT/WT) and a refractive index of 1.52. Prepa-
ration and characterization of elastomer material properties (Young’s 
modulus and Poisson’s ratio) were performed as described previously 
(Cesa et al., 2007). In brief, prepolymer mixtures were degassed and 
subsequently spin-coated on ∼100-µm-thin coverslips (thickness #0) 
to obtain an 80-µm-thick elastomer layer. Cross-linking was performed 
at 60°C overnight. Elastomeric substrates were subsequently glued to 
the bottom of 3.5-cm Petri dishes to cover predrilled 1.5-cm holes. The 
BAC-transgenic FHOD1 embryonic stem cell line was generated es-
sentially as described previously (Poser et al., 2008). Embryonic stem 
cells (cell line R1/E, obtained from A. Bird, Max Planck Institute of 
Molecular Physiology, Dortmund, Germany) were cultivated on 0.1% 
gelatin in DMEM with 10% FBS, 50 U/ml penicillin and 50 µg/ml 
streptomycin, 1% MEM-NEAA, 1% GlutaMAX, 0.1 mM β-Mercap-
toethanol and 10 ng/ml leukemia inhibitory factor (LIF; protein fac-
tory) at 37°C and 5% CO2. EGFP and G418 resistance was introduced 
into the N-terminal region of the FHOD1 gene in BAC RP24-131O24 
(Chori) via recombineering. The modified BAC was transfected into 
embryonic stem cells using Lipofectamine 2000 (Life Technologies), 
and individual clones were isolated after selection using 200 µg/ml 
G418. For TIRF microscopy, embryonic stem cells were plated on 
5 µg/ml laminin LN511 in the continued presence of LIF.
Constructs and siRNAs
delCMV-mCherry-actin was described previously (Watanabe and 
Mitchison, 2002; Schulze et al., 2014). The Rho and Cdc42 activity 
sensors delCMV-EGFP-Rhotekin-GBD, delCMV-mCherry-Rhotekin- 
GBD and delCMV-WASP-GBD were generated analogously by PCR 
amplification of the Rhotekin RhoA-binding domain from mCherry- 
Rhotekin (8–89)-mCherry-C1 (Murakoshi et al., 2011; plasmid 29675; 
Addgene) and the N-WASP GBD from pΔSV40-mCherry-WASP-
GBD (pAL198, plasmid 22281; Addgene; Levskaya et al., 2009) and li-
gated into delCMV-mCherry/delCMV-EGFP using EcoRI and BamHI 
sites. The Rac1 activity sensor delCMV-mCherry-p67phox-GBD was 
generated likewise using pGEX-4T-I-p67phox-aa1–203 (Lapouge et al., 
2000; gift of M.R. Ahmadian, Heinrich Heine University, Düsseldorf, 
Germany) as a PCR template. EGFP-GEF-H1 WT, EGFP-GEF-H1 
C53R (deficient in microtubule binding), and EGFP-GEF-H1 C53R 
Y393A (deficient in microtubule binding and GEF activity) con-
structs, as well as the siRNA-resistant constructs EGFP-GEF-H1 WT 
R9 and EGFP-GEF-H1 Y393A R9, were described previously (Kren-
del et al., 2002; Birkenfeld et al., 2007; Chang et al., 2008). The siR-
NA-resistant construct EGFP-GEF-H1 WT F539A I541E (deficient 
in binding to active Rho) was created based on Medina et al. (2013) 
via site-directed mutagenesis PCR of EGFP-GEF-H1 WT R9 using 
the primers 5′-CCA GGA GAA AGG GATGGCACTGGAAAGC GCA 
GCC CCA CCT GAG-3′ and 5′-GGT GGG GCT GCG CTTTCCAGT 
GCCAT CCC TTT CTC CTG GTT GG-3′. The same primers were used 
to generate EGFP-GEF-H1 C53R F539A I541E (deficient in binding 
to microtubules and active Rho) from EGFP-GEF-H1 C53R. EGFP- 
Ect2 WT und EGFP-Ect2 414–882 (ΔN5; constitutive active as 
described in Saito et al., 2004) were a gift of J.  Birkenfeld (Sanofi 
Aventis Deutschland GmbH, Frankfurt, Germany). EGFP-NMH CIIA 
(Wei and Adelstein, 2000; plasmid 11347), GFP-RhoA (Roberts et al., 
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2008; plasmid 23224), and mCherry-NMH CIIA (Dulyaninova et al., 
2007; plasmid 35687) plasmids were obtained from Addgene. delC-
MV-EGFP-FHOD1 WT was described previously (Schönichen et al., 
2013). WT p190RhoGAP and its GAP-inactive mutant, p190RhoGAP 
DN, cloned in pEGFP-C1 were provided by K. Burridge (University 
of North Carolina, Chapel Hill, NC; Maddox and Burridge, 2003). 
pEGFP-Myo9b and its GAP-inactive mutant, pEGFP-Myo9b-
R1695M, were supplied by M. Bähler (University of Münster, Mün-
ster, Germany; van den Boom et al., 2007). EGFP-CAAX was a gift 
of P. Bastiaens (Max Planck Institute of Molecular Physiology, Dort-
mund, Germany). GFP-LARG FL was provided by P.B. Wedegaert-
ner (Thomas Jefferson University, Philadelphia, PA; Grabocka and 
Wedegaertner, 2007). All plasmid DNA was transfected using Lipo-
fectamine 2000. siRNAs were purchased from GE Healthcare Dhar-
macon. ON-TAR GETplus siRNA GEF-H1 #9 (LQ-009883-00-0002) 
was used to deplete GEF-H1 (Chang et al., 2008). ON-TAR GETplus 
SMA RTpool Ect2 siRNA was used to deplete Ect2 (L-006450-00-
0005). ON-TAR GETplus nontargeting siRNA #2 (D-0018-10-02-05) 
was used as control (ntsiRNA). U2OS cells were transfected with 
5 nM of the respective siRNAs immediately after plating (fast forward 
transfection) using HiPerFect (Qiagen) and replated on the next day. 
Subsequent experiments were performed 72 h after siRNA transfec-
tion. Knockdown efficiency was determined by Western blot analysis.
Immunofluorescence
Untreated cells or cells treated with 30 µM nocodazole for 45 or 90 min 
were fixed with ice-cold methanol for 20 min at −20°C, washed three 
times with PBS, and incubated in blocking solution (2% BSA in PBS) 
for 1 h at RT. Coverslips were incubated with anti–α-tubulin antibody 
(1:500 [MCA77G]; Bio-Rad) in blocking solution for 1 h, washed with 
PBS, and incubated with Alexa Fluor 488–conjugated goat anti–rat sec-
ondary antibody (1:500; Invitrogen) in blocking solution for 1 h at RT. 
Samples were washed with PBS and mounted on glass slides using 
ProLong Gold antifade reagent (Invitrogen).
Western blot analysis
Cells were washed once with ice-cold PBS and lysed in ice-cold RIPA 
buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% NP-40, 0.25% sodium 
deoxycholate, 1 mM EDTA, 1× protease inhibitor cocktail, and 1× phos-
phatase inhibitor cocktail). Cell debris was removed by centrifugation 
at 14,000 g for 15 min at 4°C. Protein concentration in the supernatants 
was determined via Bradford assay. Equal amounts of total protein were 
mixed with 5× Laemmli sample buffer, boiled at 95°C for 10 min and 
separated by SDS-PAGE. After electrophoresis, proteins were transferred 
on a PVDF membrane using a semidry blotter. Blots were blocked for 
30–60 min at RT with 5% BSA in TBS-T (20 mM Tris, pH 7.6, 137 mM 
NaCl, and 0.1% Tween-20) and incubated overnight at 4°C with primary 
antibodies anti–GEF-H1 (1:200; 55B6; Cell Signaling), anti-Ect2 (1:500; 
C-20; Santa Cruz Biotechnology), and anti–α-Tubulin (1:20,000; clone 
B-5-1-2; Sigma-Aldrich) in blocking solution. Membranes were washed 
three times with TBS-T and incubated with HRP-conjugated anti–mouse 
(for anti–α-Tubulin) or anti–rabbit (for anti–GEF-H1) secondary antibod-
ies (1:20,000) for 1 h at RT. After additional washing steps with TBS-T and 
TBS (20 mM Tris, pH 7.6, and 137 mM NaCl), proteins were visualized 
with ECL Western blotting substrate.
Microscopy
TIRF and confocal spinning disk microscopy were performed on an 
Eclipse Ti-E (Nikon) inverted microscope with a motorized TIRF Illu-
minator Unit, an AOTF Laser Combiner, a laser dual spinning disk scan 
head (CSU-X1; Yokogawa), and an iXon3 897 single-photon-detection 
EMC CD camera. Laser lines used for excitation of EGFP and mCherry 
were 488 and 561 nm, respectively. Images were acquired using an 
Apo TIRF 100× 1.49 NA oil-immersion objective (Nikon) with an EM 
gain of 50–100 and 2 × 2 binning. A dual bandpass dichroic mirror 
(zt488/561rpc) was used in combination with a CSU Quad Dichroic 
mirror/emission filter set (405/488/568/647 nm). Acquisition was con-
trolled by Andor IQ Software. In some experiments, TIRF microscopy 
was conducted on an IX-81 microscope (Olympus), equipped with a 
TIRF-MIT ICO motorized TIRF illumination combiner, an Apo TIRF 
60× 1.45 NA oil-immersion objective and a ZDC autofocus device. On 
that setup, a triple bandpass dichroic mirror (U-M3TIR405/488/561,) 
was used in combination with an emission filter set (HC 520/35 and 
HC 629/53), the 488 nm line of a 400-mW argon ion laser, and the 
Cell R diode laser 561 (100 mW). For detection, this was combined 
with an EMC CD camera at medium gain without binning. Both micro-
scopes are equipped with temperature-controlled incubation chambers. 
Time-lapse live-cell microscopy experiments were performed at 37°C 
in CO2-independent medium (HBSS buffer, 10% FBS, 2 mM l-Gluta-
mine, 10 mM Hepes, 1 mM MgCl2, and 1 mM CaCl2) with indicated 
frame rates. Confocal laser scanning microscopy of fixed cells was per-
formed on a TCS SP5 AOBS system (Leica Microsystems) equipped 
with an HCX PL APO 63×/1.4 NA oil-immersion objective. Excitation 
of Alexa Fluor 488 was performed with the 488-nm line of an argon 
laser. Fluorescence was measured using the HyD detector (490–540 
nm). Acquisition was controlled using LAS AF software (Leica Mi-
crosystems). Confocal z stacks were acquired with 210-nm spacing, 
and maximum projections were generated with ImageJ.
Characterization of the mCherry-p67phox-GBD–based Rac1 activity 
sensor by optogenetics
HeLa cells cultured using standard conditions were cotransfected on fi-
bronectin-coated (Sigma Aldrich) LabTek plates with the Rac1 activity 
sensor construct (mCherry-p67phox-GBD) and photoactivatable Rac1 
(mCitrine-PA-Rac1; Wu et al., 2009) using XtremeGene 9 (Roche 
Diagnostics). Light-based activation of mCitrine-PA-Rac1 was per-
formed by wide-field illumination using a Brightline HC 427/10 filter 
(Semrock) in the MT-20 illumination device (Olympus). The built-in 
neutral-density filter wheel of the MT-20 device was used to control 
light intensity. To prevent saturated PA-Rac1 activation at low intensity 
settings, an additional 1,000× neutral-density filter was added into the 
blue light–illumination light path. Rac1 activity sensor signal measure-
ments were performed using TIRF illumination at 561 nm essentially 
as described in the previous paragraph (TIRF-M system; Olympus).
Data analysis
Except if noted otherwise, we considered the entire adhesion area of the 
cell for quantitative analysis of signal changes and cross-correlation. 
Therefore, measurements of peak width, frequency, height, and 
cross-correlation were averaged over the whole cell and were usually 
lower than measurements shown in selected cell areas.
Spatial and temporal cross-correlation analyses. To determine 
the temporal cross-correlation functions, image sequences were ob-
tained at a frame rate of 20/min. To minimize influence of noise, images 
were obtained with 2 × 2 binning and in addition, image x-y resolution 
was scaled down by a factor of 15–20 using the averaging command 
in ImageJ. The Pearson product-moment correlation coefficient of 
time-shifted corresponding images was calculated using custom Mat-
lab scripts. To determine the spatiotemporal cross-correlation function, 
the original 2 × 2–binned image sequences were used, in which time 
shifting was combined with spatial shifting of corresponding image 
sequences by steps of four pixels. Half-time and decay length of 
cross-correlation analyses were obtained by fitting the corresponding 
graphs to monoexponential decay functions.
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Radial intensity distribution. Analysis of the radial intensity 
distribution was performed similarly as described previously (Möhl et 
al., 2012). In brief, all 150 frames of image sequences from spreading 
cells were included in the analysis. The centroid of cells was determined 
in each frame via the built-in ImageJ function and used for polar 
coordinate transformation by an external ImageJ plugin (http ://rsb .info 
.nih .gov /ij /plugins /polar -transformer .html). Polar transformed images 
were stretched to reach a constant radius via linear interpolation. The 
mean distribution corresponding to all angles and frames from the 
centroid to the periphery was calculated via a custom-built ImageJ 
macro.
Analysis of standard deviation, mean frequency, peak am-
plitude, and peak width of activity pulses. Because of the irregular 
nature of the majority of activity pulses, standard methods to study 
more regular oscillations, such as Fourier analysis, were not optimal. 
Instead, we analyzed the variation of signal intensity in time series to 
directly extract their characteristics using a custom-built ImageJ macro. 
In brief, image sequences were obtained at a frame rate of 3 or 20 per 
minute with 2 × 2 binning and scaled down by a factor of 15–20 using 
averaging to reduce noise. Individual cells in image sequences were 
isolated, masked, and corrected for background intensity. The periph-
eral pixels were removed using a single application of the binary erode 
filter with neighborhood count of 1 to avoid measurements of signal 
changes that originate from dynamic cell protrusion and to focus analy-
sis of the analysis of signal dynamics in the cell center. Global intensity 
changes that affect the entire cell were removed by normalizing signals 
to the mean background-corrected intensity in each time frame. In each 
pixel, intensity changes were determined over time and analyzed as 
follows. To directly obtain the overall local variability associated with 
irregular activity pulses, the standard deviation was calculated for each 
scaled-down pixel over time. We called this normalized measurement 
“local standard deviation.” To identify intensity peaks, the intensity was 
analyzed in each pixel at each time point of the time series. Only, if 
the intensity at the given time point was higher than the following and 
preceding intensity, a time point was considered a peak. To limit the 
effect of noise, only those peaks that were >1% of the mean intensity 
of the time series were measured. In addition, a walking mean of seven 
frames was calculated for videos with a frame rate of 20 per minute. 
The peak height was determined as the difference between the peak in-
tensity and the mean of the following and preceding intensity minima. 
The peak width was determined as the time difference between these 
intensity minima. To analyze pulse frequency, only the most prominent 
peaks that were >10% of the mean intensity of the time-series were 
counted. Generation of graphs, curve fitting and statistical analysis 
were performed using GraphPad Prism 5 software. Red lines in scatter 
dot plots denote mean values. Stars denote p-values for indicated sta-
tistical tests (*, P < 0.05; **, P < 0.01; ***, P < 0.001). Figures were 
prepared using Photoshop CS2014 (Adobe).
STI CS analysis. STI CS analysis was used to generate vector maps 
of the flow of myosin signal inhomogeneities. Analysis was performed 
on myosin image sequences (20 frames/min) using an ImageJ plugin 
(http ://research .stowers .org /imagejplugins /ics _plugins .html). A cus-
tom ImageJ macro was used to calculate a series of vector maps, each 
of which was based on subsequences containing two frames before 
and after the respective time point. The divergence of each vector map 
was determined using the built-in Matlab function. The inward flow of 
the vector map corresponds to the negation of the divergence and thus 
represents the contractile flow of the myosin signal inhomogeneities.
Fourier analysis. To analyze the regular oscillations that were 
induced by overexpression of Myo9b, we generated the power spectrum 
of intensity time series via a fast-Fourier transform algorithm. First, the 
image x-y resolution of time series was scaled down by a factor of 15 
using averaging, and the resulting time series were analyzed separately 
in each pixel. The time series were divided by the mean intensity, and 
a constant value of 1 was subtracted to normalize the mean intensity 
to 0. The decrease in the intensity baseline caused by bleaching was 
obtained by fitting the mean signal from individual cells to the “one-
phase decay” function using Prism, followed by baseline subtraction. 
Fourier transformation was performed by sequential application of 
the “stack temporal fft jeu v1” and the “complex amp jeu v1” ImageJ 
plugins (http ://research .stowers .org /imagejplugins /ics _plugins .html). 
The mean power spectrum per cell was obtained from the plugin output 
via the “Plot Z-axis Profile” ImageJ function.
Online supplemental material
Fig. S1 shows Rho activity, myosin localization dynamics, and con-
trol measurements in resting and spreading cells. Fig. S2 shows 
nocodazole-treatment control experiments, Rho activity dynamics, 
and control measurements in resting, nocodazole-treated, GEF-
H1–depleted and LARG-overexpressing cells and Western blots of 
siRNA-treated cells. Fig. S3 shows RhoA localization dynamics, Rac1 
sensor control experiments, and cross-correlation analyses of Rho ac-
tivity with Rac1 or Cdc42 activity or FHOD1 localization and FHOD1 
localization dynamics in embryonic stem cells. Fig. S4 shows a scheme 
for contractile node formation and cross-correlation analyses of Rho 
activity with WT or GAP-deficient p190RhoGAP. Fig. S5 shows Rho 
activity dynamics before and after Y27632 treatment and control ex-
periments for blebbistatin and Y27632. Video  1 shows Rho activity 
dynamics in resting and nocodazole-treated cells. Video 2 shows Rho 
activity dynamics in GEF-H1 C53R–overexpressing cells. Video  3 
shows Rho activity dynamics in GEF-H1–overexpressing and GEF-
H1–depleted cells. Video  4 shows analyses of Rho activity together 
with control sensor (EGFP only), GEF-H1 localization, Cdc42 activity, 
and Rac1 activity. Video 5 shows analyses of Rho activity together with 
myosin localization. Video 6 shows Rho activity dynamics in the pres-
ence of WT or GAP-deficient Myo9b. Video 7 shows Rho activity and 
myosin localization before and after blebbistatin treatment. Video  8 
shows myosin localization dynamics on elastic surfaces.
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